Filing Details

Accession Number:
0000899243-16-018345
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-20 16:52:03
Reporting Period:
2016-04-18
Filing Date:
2016-04-20
Accepted Time:
2016-04-20 16:52:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH Pharmaceutical Preparations (2834) 330702205
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611283 G. Diane Gerst C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Evp, Qa & Regulatory Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-04-18 8,210 $10.48 39,713 No 4 M Direct
Common Stock Acquisiton 2016-04-18 6,000 $11.41 45,713 No 4 M Direct
Common Stock Disposition 2016-04-18 15,637 $12.83 30,076 No 4 S Direct
Common Stock Acquisiton 2016-04-19 5,607 $10.48 35,683 No 4 M Direct
Common Stock Disposition 2016-04-19 5,607 $13.04 30,076 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2016-04-18 6,000 $0.00 6,000 $11.41
Common Stock Employee Stock Option (right to buy) Disposition 2016-04-18 8,210 $0.00 8,210 $10.48
Common Stock Employee Stock Option (right to buy) Disposition 2016-04-19 5,607 $0.00 5,607 $10.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,000 2021-03-08 No 4 M Direct
11,790 2022-11-07 No 4 M Direct
6,183 2022-11-07 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2016.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.62 to $12.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.91 to $13.13, inclusive.
  4. Shares subject to the option vest in five equal annual installments beginning on March 8, 2012.
  5. Shares subject to the option vest in four equal annual installments beginning on November 7, 2013.